Pathology and pathophysiology of inhalational anthrax in a guinea pig model.
Nonhuman primates (NHPs) and rabbits are the animal models most commonly used to evaluate the efficacy of medical countermeasures against anthrax in support of licensure under the FDA's "Animal Rule." However, a need for an alternative animal model may arise in certain cases. The development of such an alternative model requires a thorough understanding of the course and manifestation of experimental anthrax disease induced under controlled conditions in the proposed animal species. The guinea pig, which has been used extensively for anthrax pathogenesis studies and anthrax vaccine potency testing, is a good candidate for such an alternative model. This study was aimed at determining the median lethal dose (LD50) of the Bacillus anthracis Ames strain in guinea pigs and investigating the natural history, pathophysiology, and pathology of inhalational anthrax in this animal model following nose-only aerosol exposure. The inhaled LD50 of aerosolized Ames strain spores in guinea pigs was determined to be 5.0 × 10(4) spores. Aerosol challenge of guinea pigs resulted in inhalational anthrax with death occurring between 46 and 71 h postchallenge. The first clinical signs appeared as early as 36 h postchallenge. Cardiovascular function declined starting at 20 h postexposure. Hematogenous dissemination of bacteria was observed microscopically in multiple organs and tissues as early as 24 h postchallenge. Other histopathologic findings typical of disseminated anthrax included suppurative (heterophilic) inflammation, edema, fibrin, necrosis, and/or hemorrhage in the spleen, lungs, and regional lymph nodes and lymphocyte depletion and/or lymphocytolysis in the spleen and lymph nodes. This study demonstrated that the course of inhalational anthrax disease and the resulting pathology in guinea pigs are similar to those seen in rabbits and NHPs, as well as in humans.
Emergent BioSolutions Inc., Gaithersburg, Maryland, USA.
Vladimir
V
Savransky
Daniel C
DC
Sanford
Emily
E
Syar
Jamie L
JL
Austin
Kevin P
KP
Tordoff
Michael S
MS
Anderson
Gregory V
GV
Stark
Roy E
RE
Barnewall
Crystal M
CM
Briscoe
Laurence
L
Lemiale-Biérinx
Sukjoon
S
Park
Boris
B
Ionin
Mario H
MH
Skiadopoulos
D000818:Animals; D000881:Anthrax / Q000401:mortality / Q000473:pathology* / Q000503:physiopathology*; D001408:Bacillus anthracis / Q000472:pathogenicity*; D004195:Disease Models, Animal; D005260:Female; D006168:Guinea Pigs; D007928:Lethal Dose 50; D008297:Male; D016019:Survival Analysis; D013997:Time Factors